key: cord-0717372-6se208zg
authors: Diao, Bo; Wen, Kun; Zhang, Ji; Chen, Jian; Han, Chao; Chen, Yongwen; Wang, Shufeng; Deng, Guohong; Zhou, Hongwei; Wu, Yuzhang
title: Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection
date: 2020-10-05
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.09.057
sha: 306590c0ed61e1c3a7be20dd21c0135064e5686a
doc_id: 717372
cord_uid: 6se208zg

OBJECTIVE: Rapid, reliable, and easy-to-implement diagnostics that can be adapted in early SARS-CoV-2 diagnosis are critical to combat the epidemic. SARS-CoV-2 nucleocapsid protein (NP) is an ideal target for viral antigen-based detection. A rapid and convenient method was developed based on fluorescence immunochromatographic (FIC) assay to detect the SARS-CoV-2 NP antigen. However, the accuracy of this diagnostic method needs to be examined. METHODS: This prospective study was carried out between February 10 and 15, 2020 in 7 hospitals of Wuhan and 1 hospital of Chongqing, China. Participants with clinically suspected SARS-CoV-2 infection were enrolled. NP antigen testing by FIC assay and nucleic acid (NA) testing by RT-PCR were performed simultaneously in a blind manner with the same nasopharyngeal swab sample. The diagnostic accuracy of NP antigen testing was calculated by taking NA testing of RT-PCR as reference standard, in which samples with cycle threshold (Ct) value ≤ 40 were interpreted as SARS-CoV-2 positives. RESULTS: A total of 253 participants were enrolled and 2 participants were excluded from the analyses due to invalid NP testing results. Of 251 participants (99.2%) that were included in the diagnostic accuracy analysis, a total of 201 participants (80.1%) had a Ct value ≤40. With Ct value 40 as the cut-off of NA testing, the sensitivity, specificity, and percent agreement of the FIC assay was 75.6% (95% CI 69.0%-81.3%), 100% (95% CI 91.1%-100%), and 80.5% (95% CI 75.1%-84.9%), respectively. CONCLUSIONS: With RT-PCR assay as reference standard, NP antigen testing by FIC assay shows high specificity and relative high sensitivity in SARS-CoV-2 diagnosis in the early phase of infection.

an ideal target for viral antigen-based detection. A rapid and convenient method was developed based 23 on fluorescence immunochromatographic (FIC) assay to detect the SARS-CoV-2 NP antigen. However, 24 the accuracy of this diagnostic method needs to be examined. 

Two different members (B Diao and J Zhang) of the study team did data entry, and the data entered

The pandemic of COVID-19 is a public health concern; however, the diagnosis is difficult due to its 153 non-featured clinical manifestations and symptoms. Rapid, reliable, and easy-to-implement diagnostics 154 that can be applied to SARS-CoV-2 are an urgent requirement. Herein, we show that compared to 155 RT-PCR, NP antigen-based assay has high specificity and relative high sensitivity in SARS-CoV-2 156 diagnosis in the early phase of infection. In addition, despite the lack of complete clinical information, 157 we noticed that a proportion of NP antigen detection assay-positive samples were of these patients who 158 had fever or fatigue or cough onset within 1 day.

Various techniques can be used to detect virus antigens. Compared to colloidal gold 160 immunochromatography assay (GICA) that may be used for point-of-care, the experimental operation 161 of the FIC assay is less fast and less convenient; however, it has higher sensitivity in diagnosis [14, 15] .

On the other hand, compared to NA testing by RT-PCR or next-generation sequencing, this method is 163 fast and reliable to identify SARS-CoV-2-infected individuals. In practice, NP antigen-based FIC assay 164 may not be used to replace NA testing, but the combination with RT-PCR will substantially improve 165 the diagnostic capability.

Nevertheless, the present study has some limitations. First, the sample size of this study was small.

Second, the detailed medical information of some participants in this study was not available, and 168 hence, data could not be correlated with symptoms or disease course. Third, participants in this study 169 were suspected COVID-19 patients with symptoms, while individuals without symptoms were not 

Diagnostic testing for the novel coronavirus

protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2

Monoclonal antibody-based antigen capture 200 enzyme-linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase 201 sera of severe acute respiratory syndrome patients

A new coronavirus associated with human 203 respiratory disease in China

Nucleocapsid protein as early diagnostic marker 205 for SARS

In vitro diagnostics of coronavirus disease 2019: 207 Technologies and application

A fluorescence immunochromatographic 209 assay using Europium (III) chelate microparticles for rapid, quantitative and sensitive detection of 210 creatine kinase MB

FIND (Foundation for Innovative New Diagnostics)

Cut-off Ct values of RT-PCR* Number of patients (%) (n=251)

According to the recommendation for COVID-19 diagnosis of the Chinese CDC, samples with Ct 223 value＞40 were considered as SARS-CoV-2 negative

SARS-CoV-2 positive, while samples with 37＜Ct≤40 were considered as indeterminate that need a 225 second sampling and RT-PCR assay

Abbreviations: RT-PCR, real-time reverse transcriptase-polymerase chain reaction

According to the instructions of the PCR kit, samples with cycle threshold (Ct) value ≤40 were 231 interpreted as SARS-CoV-2 positive, and samples with Ct value＞40 were considered as SARS-CoV-2 232 negative

All authors have completed and submitted the ICMJE Form for Disclosure of